Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trialJeffrey I. Zwicker, Alok A. Khorana, Mäneka Puligandla et al.|Blood Advances|2020Cited by 31